Objective: Patients with auditory neuropathy spectrum disorder (ANSD) exhibit altered neural synchrony in response to auditory stimuli. Cochlear implantation (CI) is thought to improve neural synchrony in response to auditory stimuli and improve speech perception relative to conventional hearing amplification (HA).
Results: Average follow-up for all patients was 36 months (range 0-90). Two of 7 observed patients exhibited neuromaturation over time. Median available pretreatment IT-MAIS scores were 13 and 34 for CI and HA groups, respectively (difference NS, rank sum test, P = .06). All CI patients had a prior HA trial with failure of auditory skills development. Posttreatment, 15/20 CI patients and 5/11 HA patients with available data achieved closed/open-set speech perception scores ≥60%. No differences between groups were found in post-treatment IT-MAIS scores (rank sum test, P = .69) or the percentage of patients achieving the above levels of closed/ open-set speech perception (Fisher's exact test, P = .13).
Conclusion: In our ANSD population, patients undergoing CI achieved at least comparable and possibly improved overall speech perception outcomes relative to HAs despite a greater initial level of auditory impairment as assessed by parent questionnaire. These findings further validate use of CIs in ANSD patients with failure of auditory skills development.
Otology/Neurotology
Combination Therapy for the Treatment of idiopathic SSNHl Alex Battaglia, MD, PhD (presenter); Annette Lualhati; Raoul Burchette; Roberto A. Cueva, MD Objective: To determine whether combination therapy (highdose prednisone taper [HDPT]+intratympanic dexamethasone [IT-Dex]) improves pure tone average scores (PTA) and speech discrimination scores (SDS) relative to HDPT alone or intratympanic steroid (IT-S) alone in patients with idiopathic sudden sensorineural hearing loss (ISSNHL).
Method: From June 2008 to January 2012, 84 (15 dropouts) patients diagnosed with ISSNHL were administered IT-De (10 mg/cc) once-a-week for 3 weeks + HDPT (60 mg/day for 7 days with 7-day taper). Final audiogram results are compared to previously published results of combination therapy, HPDT alone, and IT-S alone.
Results: Treatment began on average 6.6 days after onset of ISSNHL. The average pretreatment 3-tone PTA was 83.2, and the average pretreatment SDS was 16%. The overall PTA improved significantly by an average of -38. The overall SDS improved significantly by an average of 49%. The average overall posttreatment SDS was 65%. 60/69 (87%) patients started with an SDS score less than or equal to 50%, and 38 (63%) of these ended above 50%. 24/42 (57%) of the profound patients recovered with an SDS above 50%. According to published reports, HDPT and IT-S alone improve SDS by only 39%.
Conclusion: ISSNHL patients treated with IT-De+ HDPT experienced statistically significant PTA and SDS improvements, comparable to previously published combination therapy results. The audiologic data indicate that combination therapy improves hearing recovery relative to HDPT or IT-S alone, possibly by improving hair cell and spiral ganglion survival.
Otology/Neurotology Comparison of Packing Material in Middle Ear Mucosal Trauma
Ralph Abi Hachem, MD (presenter); Enrique Perez, MD; Isabel Bueno, MD; Thomas R. Van De Water, PhD; Simon I. Angeli, MD Objective: To compare absorbable gelatin sponge (AGS) with polyurethane foam (PUF) as middle ear packing material after mucosal trauma.
Method: Controlled animal experiment. Thirty-six guinea pigs underwent middle ear surgery with mucosal trauma performed on both ears. One ear was packed with either PUF or AGS. Contralateral ears were used as nonpacked paired controls. Auditory brainstem response (ABR) thresholds were measured preoperatively and repeated at 1, 2, and 6 weeks postoperatively. Histological analysis was done by a pathologist blinded to the type of packing using hematoxylin and eosin staining to measure inflammatory reaction and trichome staining to measure fibrosis in each group.
Results: ABR recordings demonstrates that threshold level changes from baseline were minor in the PUF and the control groups. Threshold levels were higher in the AGS group compared with both control groups and the PUF group for the 1 KHz and 0.5 KHz frequencies. Macoscopic analysis showed no tympanic membrane perforation and packing material was absorbed in all groups at 6 weeks postoperatiely. The histological analysis showed normal mucosal healing in the PUF and control groups. There was more packing retention, inflammation, and osteoneogenesis in the AGS group than the PUF or either control group.
ORAL PRESENTATIONS
Conclusion: Following surgical trauma, the middle ear mucosa healed well without packing or with PUF packing material, and hearing was not affected. In contrast AGS packing material showed hearing loss at low frequencies and osteogenesis.
Otology/Neurotology Complications after Cochlear implantation in Older Adults
Danisa M. Clarrett, MS (presenter); Lingsheng Li; Frank R. Lin, MD Objective: 1) Analyze the postoperative complications associated with cochlear implantation (CI) surgery in older adults. 2) Understand how the safety profile of CI in older adults compares with that in children and younger adults.
Methods:
We conducted a retrospective chart review of all individuals aged 60 years or older who underwent a first CI from 1999-2011 at Johns Hopkins to abstract data on postoperative follow-up and complications. Statistical analyses comparing observed complication frequencies were performed using goodness-of-fit Fisher exact tests.
Results: From 1999-2011, 445 individuals 60 years or older received a first cochlear implant at Johns Hopkins. The mean age at implantation was 72.7 years (range 60-94.9 years) and the median duration of follow-up was 4.8 years (range 0.1-12.5 years). There were a total of 42 minor complications in 41 patients (9.2%) and 36 major complications in 21 patients (4.7%). There were no cases of meningitis or postoperative facial paralysis. Seventeen patients (3.8%) required surgical device removal. Complication rates did not differ between individuals 60-75 years and those 75 years or older except for balance problems which were slightly more prevalent in the older cohort (9.5% vs 4.9%, P = .05).
Conclusion:
Our results demonstrate that CI in older adults has a safety profile comparable to CI in younger adults and children. We suggest that concerns for increased postoperative complications in patients of advanced age should not be considered when determining CI candidacy.
Otology/Neurotology Complications and Clinical Analysis of Cochlear implatations Jianhua Qiu, MD, PhD (presenter)
Objective: To investigate complications of cochlear implantation for prevention and therapy.
Method: Retrospective study at a tertiary referral center. The patients (n = 673) who received cochlear implants in our department between 2000 and 2011 were followed up (range, 6 months to 10 years). All complications were systematically reviewed, and their causes were analyzed for prevention and therapy.
Results: There were a total of 33 complications (4.9%). The minor were 26 cases (3.9%), including postoperative subcutaneous hematoma in 14 cases, acute otitis media in 2 cases, postoperative wound infection in 2 cases, delayed facial paralysis in 1 case, clonic facial spasm in 1 case, and severe dizziness in 6 cases. The major were 7 cases (1.1%), including cerebrospinal fluid leakage in 2 cases, implant-related infection and extrusion in 2 cases, tympanic membrane perforation induced electrode exposed in 1 case, implantation failure due to cochlear ossification in 1 case, and magnet displacement in 1 case.
Conclusion:
Cochlear implantation is a safe and reliable operation, but it is still a serious problem to lower the incidence of complications.
Otology/Neurotology Cytokines induced by Gentamicin and Sepsis in the Cochlea
Lourdes Quintanilla-Dieck, MD (presenter); Barbara Larrain; Dennis R. Trune, PhD; Peter Steyger, MD Objective: The mechanism by which sepsis-induced inflammation enhances aminoglycoside trafficking into the cochlea remains poorly understood. This study sought to determine if protein expression of inflammatory-mediated cytokines in the cochlea is modulated by systemic sepsis and/or drug treatment.
Method: Three groups of mice received 1 of the following treatments: gentamicin, lipopolysaccharide for sepsis induction, or both gentamicin and lipopolysaccharide. A fourth group served as controls. After sacrifice, cochleae were collected and homogenized for protein extraction. This was followed by an enzyme-linked immunosorbent assay for analysis of 16 inflammatory-mediated cytokines.
Results: There was substantial elevation in cochlear expression of multiple cytokines in mice treated with bacteria-derived lipopolysaccharide, with or without gentamicin. The most salient cytokines were interleukin-1α, interleukin-6, monocyte chemotactic protein-1, and macrophage inflammatory protein-α. Gentamicin alone did not induce a significant inflammatory response, compared to lipopolysaccharide. This suggests that in the cochlea, specific pro-inflammatory cytokines are massively produced during a systemic infection, but not in the presence of aminoglycosides as the sole insult. Given that these cytokines increase permeability across bloodendothelial barriers, permitting transendothelial migration of inflammatory cells, they may also enhance aminoglycoside trafficking and contribute to its ototoxicity.
Conclusion:
Aminoglycosides are usually prescribed for prophylaxis or systemic bacterial infection. The latter induces a pro-inflammatory state that could enhance aminoglycoside uptake by cochlear tissues. Unveiling the mechanisms mediated by sepsis that contribute to cochlear uptake of aminoglycosides will aid the development of strategies to ameliorate or prevent this devastating side-effect.
